The global Pediatric Drug Development Services market was valued at US$ 1329 million in 2025 and is anticipated to reach US$ 1935 million by 2032, at a CAGR of 5.6% from 2026 to 2032.

Pediatric Drug Development Services Market

Pediatric drug development services refer to professional services for drug research and development tailored to the needs of pediatric patients. These services include drug safety assessment, pharmacodynamics studies, clinical trial design, and other aspects. Pediatric Drug Development Services aim to ensure the safety and efficacy of drugs in pediatric patients, providing more appropriate treatment options for children. This service is of great significance in the field of pediatrics, contributing to improved child health and quality of life.

The North American market for Pediatric Drug Development Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Pediatric Drug Development Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Pediatric Drug Development Services in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Pediatric Drug Development Services include IQVIA, Lonza, Fortrea, Certara, NGT BioPharma, PCI, Allucent, CTI, Sun-Novo, ICON, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Pediatric Drug Development Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pediatric Drug Development Services. The Pediatric Drug Development Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pediatric Drug Development Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pediatric Drug Development Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pediatric Drug Development Services Market Report

Report Metric	Details
Report Name	Pediatric Drug Development Services Market
Accounted market size in 2025	US$ 1329 million
Forecasted market size in 2032	US$ 1935 million
CAGR	5.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Preclinical Services Clinical Services
Segment by Application	Pharmaceutical Companies Medical Device Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	IQVIA, Lonza, Fortrea, Certara, NGT BioPharma, PCI, Allucent, CTI, Sun-Novo, ICON, Lewwin Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pediatric Drug Development Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Pediatric Drug Development Services Market growing?

Ans: The Pediatric Drug Development Services Market witnessing a CAGR of 5.6% during the forecast period 2026-2032.

What is the Pediatric Drug Development Services Market size in 2032?

Ans: The Pediatric Drug Development Services Market size in 2032 will be US$ 1935 million.

Who are the main players in the Pediatric Drug Development Services Market report?

Ans: The main players in the Pediatric Drug Development Services Market are IQVIA, Lonza, Fortrea, Certara, NGT BioPharma, PCI, Allucent, CTI, Sun-Novo, ICON, Lewwin Pharma

What are the Application segmentation covered in the Pediatric Drug Development Services Market report?

Ans: The Applications covered in the Pediatric Drug Development Services Market report are Pharmaceutical Companies, Medical Device Companies, Others

What are the Type segmentation covered in the Pediatric Drug Development Services Market report?

Ans: The Types covered in the Pediatric Drug Development Services Market report are Preclinical Services, Clinical Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatric Drug Development Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Preclinical Services

1.2.3 Clinical Services

1.3 Market by Application

1.3.1 Global Pediatric Drug Development Services Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical Companies

1.3.3 Medical Device Companies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pediatric Drug Development Services Market Perspective (2021–2032)

2.2 Global Pediatric Drug Development Services Growth Trends by Region

2.2.1 Global Pediatric Drug Development Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Pediatric Drug Development Services Historic Market Size by Region (2021–2026)

2.2.3 Pediatric Drug Development Services Forecasted Market Size by Region (2027–2032)

2.3 Pediatric Drug Development Services Market Dynamics

2.3.1 Pediatric Drug Development Services Industry Trends

2.3.2 Pediatric Drug Development Services Market Drivers

2.3.3 Pediatric Drug Development Services Market Challenges

2.3.4 Pediatric Drug Development Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pediatric Drug Development Services Players by Revenue

3.1.1 Global Top Pediatric Drug Development Services Players by Revenue (2021–2026)

3.1.2 Global Pediatric Drug Development Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Pediatric Drug Development Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Pediatric Drug Development Services Revenue

3.4 Global Pediatric Drug Development Services Market Concentration Ratio

3.4.1 Global Pediatric Drug Development Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatric Drug Development Services Revenue in 2025

3.5 Global Key Players of Pediatric Drug Development Services Head Offices and Areas Served

3.6 Global Key Players of Pediatric Drug Development Services, Products and Applications

3.7 Global Key Players of Pediatric Drug Development Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Pediatric Drug Development Services Breakdown Data by Type

4.1 Global Pediatric Drug Development Services Historic Market Size by Type (2021–2026)

4.2 Global Pediatric Drug Development Services Forecasted Market Size by Type (2027–2032)

5 Pediatric Drug Development Services Breakdown Data by Application

5.1 Global Pediatric Drug Development Services Historic Market Size by Application (2021–2026)

5.2 Global Pediatric Drug Development Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Pediatric Drug Development Services Market Size (2021–2032)

6.2 North America Pediatric Drug Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Pediatric Drug Development Services Market Size by Country (2021–2026)

6.4 North America Pediatric Drug Development Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pediatric Drug Development Services Market Size (2021–2032)

7.2 Europe Pediatric Drug Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Pediatric Drug Development Services Market Size by Country (2021–2026)

7.4 Europe Pediatric Drug Development Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pediatric Drug Development Services Market Size (2021–2032)

8.2 Asia-Pacific Pediatric Drug Development Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Pediatric Drug Development Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Pediatric Drug Development Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pediatric Drug Development Services Market Size (2021–2032)

9.2 Latin America Pediatric Drug Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Pediatric Drug Development Services Market Size by Country (2021–2026)

9.4 Latin America Pediatric Drug Development Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pediatric Drug Development Services Market Size (2021–2032)

10.2 Middle East & Africa Pediatric Drug Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Pediatric Drug Development Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Pediatric Drug Development Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 IQVIA

11.1.1 IQVIA Company Details

11.1.2 IQVIA Business Overview

11.1.3 IQVIA Pediatric Drug Development Services Introduction

11.1.4 IQVIA Revenue in Pediatric Drug Development Services Business (2021–2026)

11.1.5 IQVIA Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Pediatric Drug Development Services Introduction

11.2.4 Lonza Revenue in Pediatric Drug Development Services Business (2021–2026)

11.2.5 Lonza Recent Development

11.3 Fortrea

11.3.1 Fortrea Company Details

11.3.2 Fortrea Business Overview

11.3.3 Fortrea Pediatric Drug Development Services Introduction

11.3.4 Fortrea Revenue in Pediatric Drug Development Services Business (2021–2026)

11.3.5 Fortrea Recent Development

11.4 Certara

11.4.1 Certara Company Details

11.4.2 Certara Business Overview

11.4.3 Certara Pediatric Drug Development Services Introduction

11.4.4 Certara Revenue in Pediatric Drug Development Services Business (2021–2026)

11.4.5 Certara Recent Development

11.5 NGT BioPharma

11.5.1 NGT BioPharma Company Details

11.5.2 NGT BioPharma Business Overview

11.5.3 NGT BioPharma Pediatric Drug Development Services Introduction

11.5.4 NGT BioPharma Revenue in Pediatric Drug Development Services Business (2021–2026)

11.5.5 NGT BioPharma Recent Development

11.6 PCI

11.6.1 PCI Company Details

11.6.2 PCI Business Overview

11.6.3 PCI Pediatric Drug Development Services Introduction

11.6.4 PCI Revenue in Pediatric Drug Development Services Business (2021–2026)

11.6.5 PCI Recent Development

11.7 Allucent

11.7.1 Allucent Company Details

11.7.2 Allucent Business Overview

11.7.3 Allucent Pediatric Drug Development Services Introduction

11.7.4 Allucent Revenue in Pediatric Drug Development Services Business (2021–2026)

11.7.5 Allucent Recent Development

11.8 CTI

11.8.1 CTI Company Details

11.8.2 CTI Business Overview

11.8.3 CTI Pediatric Drug Development Services Introduction

11.8.4 CTI Revenue in Pediatric Drug Development Services Business (2021–2026)

11.8.5 CTI Recent Development

11.9 Sun-Novo

11.9.1 Sun-Novo Company Details

11.9.2 Sun-Novo Business Overview

11.9.3 Sun-Novo Pediatric Drug Development Services Introduction

11.9.4 Sun-Novo Revenue in Pediatric Drug Development Services Business (2021–2026)

11.9.5 Sun-Novo Recent Development

11.10 ICON

11.10.1 ICON Company Details

11.10.2 ICON Business Overview

11.10.3 ICON Pediatric Drug Development Services Introduction

11.10.4 ICON Revenue in Pediatric Drug Development Services Business (2021–2026)

11.10.5 ICON Recent Development

11.11 Lewwin Pharma

11.11.1 Lewwin Pharma Company Details

11.11.2 Lewwin Pharma Business Overview

11.11.3 Lewwin Pharma Pediatric Drug Development Services Introduction

11.11.4 Lewwin Pharma Revenue in Pediatric Drug Development Services Business (2021–2026)

11.11.5 Lewwin Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pediatric Drug Development Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Preclinical Services

Table 3. Key Players of Clinical Services

Table 4. Global Pediatric Drug Development Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Pediatric Drug Development Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Pediatric Drug Development Services Market Size by Region (US$ Million), 2021–2026

Table 7. Global Pediatric Drug Development Services Market Share by Region (2021–2026)

Table 8. Global Pediatric Drug Development Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Pediatric Drug Development Services Market Share by Region (2027–2032)

Table 10. Pediatric Drug Development Services Market Trends

Table 11. Pediatric Drug Development Services Market Drivers

Table 12. Pediatric Drug Development Services Market Challenges

Table 13. Pediatric Drug Development Services Market Restraints

Table 14. Global Pediatric Drug Development Services Revenue by Players (US$ Million), 2021–2026

Table 15. Global Pediatric Drug Development Services Market Share by Players (2021–2026)

Table 16. Global Top Pediatric Drug Development Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pediatric Drug Development Services Revenue, 2025

Table 17. Ranking of Global Top Pediatric Drug Development Services Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Pediatric Drug Development Services Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Pediatric Drug Development Services, Headquarters and Area Served

Table 20. Global Key Players of Pediatric Drug Development Services, Products and Applications

Table 21. Global Key Players of Pediatric Drug Development Services, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Pediatric Drug Development Services Market Size by Type (US$ Million), 2021–2026

Table 24. Global Pediatric Drug Development Services Revenue Market Share by Type (2021–2026)

Table 25. Global Pediatric Drug Development Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Pediatric Drug Development Services Revenue Market Share by Type (2027–2032)

Table 27. Global Pediatric Drug Development Services Market Size by Application (US$ Million), 2021–2026

Table 28. Global Pediatric Drug Development Services Revenue Market Share by Application (2021–2026)

Table 29. Global Pediatric Drug Development Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Pediatric Drug Development Services Revenue Market Share by Application (2027–2032)

Table 31. North America Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Pediatric Drug Development Services Market Size by Country (US$ Million), 2021–2026

Table 33. North America Pediatric Drug Development Services Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Pediatric Drug Development Services Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Pediatric Drug Development Services Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Pediatric Drug Development Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Pediatric Drug Development Services Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Pediatric Drug Development Services Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Pediatric Drug Development Services Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Pediatric Drug Development Services Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Pediatric Drug Development Services Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Pediatric Drug Development Services Market Size by Country (US$ Million), 2027–2032

Table 46. IQVIA Company Details

Table 47. IQVIA Business Overview

Table 48. IQVIA Pediatric Drug Development Services Product

Table 49. IQVIA Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 50. IQVIA Recent Development

Table 51. Lonza Company Details

Table 52. Lonza Business Overview

Table 53. Lonza Pediatric Drug Development Services Product

Table 54. Lonza Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 55. Lonza Recent Development

Table 56. Fortrea Company Details

Table 57. Fortrea Business Overview

Table 58. Fortrea Pediatric Drug Development Services Product

Table 59. Fortrea Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 60. Fortrea Recent Development

Table 61. Certara Company Details

Table 62. Certara Business Overview

Table 63. Certara Pediatric Drug Development Services Product

Table 64. Certara Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 65. Certara Recent Development

Table 66. NGT BioPharma Company Details

Table 67. NGT BioPharma Business Overview

Table 68. NGT BioPharma Pediatric Drug Development Services Product

Table 69. NGT BioPharma Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 70. NGT BioPharma Recent Development

Table 71. PCI Company Details

Table 72. PCI Business Overview

Table 73. PCI Pediatric Drug Development Services Product

Table 74. PCI Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 75. PCI Recent Development

Table 76. Allucent Company Details

Table 77. Allucent Business Overview

Table 78. Allucent Pediatric Drug Development Services Product

Table 79. Allucent Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 80. Allucent Recent Development

Table 81. CTI Company Details

Table 82. CTI Business Overview

Table 83. CTI Pediatric Drug Development Services Product

Table 84. CTI Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 85. CTI Recent Development

Table 86. Sun-Novo Company Details

Table 87. Sun-Novo Business Overview

Table 88. Sun-Novo Pediatric Drug Development Services Product

Table 89. Sun-Novo Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 90. Sun-Novo Recent Development

Table 91. ICON Company Details

Table 92. ICON Business Overview

Table 93. ICON Pediatric Drug Development Services Product

Table 94. ICON Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 95. ICON Recent Development

Table 96. Lewwin Pharma Company Details

Table 97. Lewwin Pharma Business Overview

Table 98. Lewwin Pharma Pediatric Drug Development Services Product

Table 99. Lewwin Pharma Revenue in Pediatric Drug Development Services Business (US$ Million), 2021–2026

Table 100. Lewwin Pharma Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Pediatric Drug Development Services Picture

Figure 2. Global Pediatric Drug Development Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Pediatric Drug Development Services Market Share by Type: 2025 vs 2032

Figure 4. Preclinical Services Features

Figure 5. Clinical Services Features

Figure 6. Global Pediatric Drug Development Services Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Pediatric Drug Development Services Market Share by Application: 2025 vs 2032

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. Medical Device Companies Case Studies

Figure 10. Others Case Studies

Figure 11. Pediatric Drug Development Services Report Years Considered

Figure 12. Global Pediatric Drug Development Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Pediatric Drug Development Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Pediatric Drug Development Services Market Share by Region: 2025 vs 2032

Figure 15. Global Pediatric Drug Development Services Market Share by Players in 2025

Figure 16. Global Pediatric Drug Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Pediatric Drug Development Services Revenue in 2025

Figure 18. North America Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Pediatric Drug Development Services Market Share by Country (2021–2032)

Figure 20. United States Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Pediatric Drug Development Services Market Share by Country (2021–2032)

Figure 24. Germany Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Pediatric Drug Development Services Market Share by Region (2021–2032)

Figure 32. China Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Pediatric Drug Development Services Market Share by Country (2021–2032)

Figure 40. Mexico Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Pediatric Drug Development Services Market Share by Country (2021–2032)

Figure 44. Israel Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Pediatric Drug Development Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. IQVIA Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 48. Lonza Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 49. Fortrea Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 50. Certara Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 51. NGT BioPharma Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 52. PCI Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 53. Allucent Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 54. CTI Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 55. Sun-Novo Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 56. ICON Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 57. Lewwin Pharma Revenue Growth Rate in Pediatric Drug Development Services Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions